Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Novel Antibody-Based Approaches on Horizon in Multiple Myeloma

Jessica Hergert
Published: Friday, Aug 30, 2019

Hearn Jay Cho, MD, PhD, an associate professor of medicine, hematology and medical oncology at Mount Sinai Hospital

Hearn Jay Cho, MD, PhD

Emerging antibody-based approaches, such as antibody-drug conjugates (ADCs), bispecific T-cell engagers (BiTEs), and CAR T-cell therapies are inducing promising response rates in patients with multiple myeloma, said Hearn Jay Cho, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication